Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with ...

The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Doctors say Marie Fundora is much more than a master of fundraising over a glass of wine and a plate of Spaghetti Cardonara ...

In patients with localized pancreatic ductal adenocarcinoma (PDAC), failure to undergo resection following neoadjuvant chemotherapy is common and associated with worse survival. Researchers identified ...

An artificial-intelligence system in China is quietly spotting one of the most lethal cancers before patients—or their ...

Hong Kong, Shanghai Tuesday, January 6, 2026, 13:00 Hrs [IST] ...

HUTCHMED has advanced its ongoing study of surufatinib and camrelizumab for treatment‑naïve metastatic pancreatic ductal ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...